Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
88.39
+2.43 (2.83%)
At close: Nov 21, 2024, 4:00 PM
88.30
-0.09 (-0.10%)
After-hours: Nov 21, 2024, 6:37 PM EST
Vaxcyte Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -507.65 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | |
| Depreciation & Amortization | 14.01 | 10.17 | 9.2 | 3.46 | 1.41 | 1.23 | |
| Loss (Gain) From Sale of Assets | - | - | 0.04 | 0.1 | 0.03 | 0 | |
| Asset Writedown & Restructuring Costs | - | - | 0.21 | - | 0.27 | - | |
| Loss (Gain) From Sale of Investments | -29.4 | -34.78 | -0.95 | 1.41 | - | - | |
| Stock-Based Compensation | 73.8 | 48.76 | 23.65 | 10.73 | 5.43 | 1.19 | |
| Other Operating Activities | -6.45 | - | 8 | - | 0.18 | -3.2 | |
| Change in Accounts Payable | 9.75 | 11.23 | 2.9 | -12.47 | 26.1 | 0.87 | |
| Change in Other Net Operating Assets | -24.1 | 70.1 | 9.84 | -24.54 | 9.17 | 3.04 | |
| Operating Cash Flow | -470.04 | -296.79 | -170.6 | -121.39 | -46.63 | -47.15 | |
| Capital Expenditures | -146.2 | -67.88 | -5.85 | -6.56 | -1.16 | -1.2 | |
| Sale of Property, Plant & Equipment | - | - | 0.01 | 0.03 | 0.05 | - | |
| Investment in Securities | -1,316 | -705.43 | 80.43 | -205.78 | - | - | |
| Investing Cash Flow | -1,462 | -773.31 | 74.59 | -212.31 | -1.11 | -1.2 | |
| Long-Term Debt Repaid | - | - | - | - | -0.06 | -0.28 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.06 | -0.28 | |
| Issuance of Common Stock | 2,460 | 643.69 | 862.41 | 17.8 | 268.45 | 0.44 | |
| Other Financing Activities | -13.54 | -3.88 | -0.86 | - | -3.4 | -1.1 | |
| Financing Cash Flow | 2,446 | 639.81 | 861.55 | 17.8 | 374.87 | 41.57 | |
| Foreign Exchange Rate Adjustments | -8.61 | -6.69 | 0.14 | -0.44 | 0.09 | -0.34 | |
| Net Cash Flow | 505.27 | -436.97 | 765.67 | -316.34 | 327.22 | -7.11 | |
| Free Cash Flow | -616.24 | -364.67 | -176.45 | -127.95 | -47.78 | -48.34 | |
| Free Cash Flow Per Share | -5.41 | -3.75 | -2.72 | -2.46 | -1.62 | -12.74 | |
| Cash Interest Paid | - | - | 0 | 0.01 | 0.01 | 0.04 | |
| Levered Free Cash Flow | -404.95 | -202.41 | -107.79 | -88.16 | -14.4 | -30.34 | |
| Unlevered Free Cash Flow | -404.95 | -202.41 | -107.79 | -88.16 | -14.39 | -30.32 | |
| Change in Net Working Capital | -30.97 | -99.06 | -10.37 | 31 | -35.91 | -2.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.